https://www.healthcentral.com/article/gilenya-fingolimod-first-ms-oral-drug-will-be-available-in-us-with-financial-help-from-novartis
Multiple Sclerosis

Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis

    Lisa Emrich

    Lisa Emrich

    @LisaEmrich

    Living with multiple sclerosis and rheumatoid Arthritis, Lisa Emrich is an award-winning, passionate patient advocate, health writer, classical musician, and backroad cyclist. Her stories inspire others to live better and stay active. Lisa is author of the blog Brass and Ivory: Life with MS and RA and founder of the Carnival of MS Bloggers. Lisa frequently works with organizations in support of better policies, patient-centered research, and research funding.

    Lisa serves on HealthCentral’s Health Advocates Advisory Board, and is a Social Ambassador for the MSHealthCentral Facebook page.